香砂六君子汤加味治疗寒凝血瘀型原发性痛经的临床观察
|
摘要
目的观察香砂六君子汤加味治疗寒凝血瘀型原发性痛经的临床疗效。方法将100例寒凝血瘀型原发性痛经患者随机分为治疗组和对照组,治疗组采用中药汤剂香砂六君子汤加味治疗,对照组口服布洛芬胶囊。结果两组治疗后VAS评分均较本组治疗前好转(P <0. 05),两组病例治疗后VAS评分比较差异有统计学意义(P <0. 01)。治疗组治疗后总有效率86. 00%,对照组治疗后总有效率74. 00%,两组病例治疗后总有效率比较差异有统计学意义(P <0. 01)。治愈后继续随访3个月,治疗组治愈后复发率为14. 28%,对照组治愈后复发率为85. 71%,治疗组明显低于对照组(P <0. 01)。结论香砂六君子汤加味治疗寒凝血瘀型原发性痛经的临床疗效显著,复发率较低,有临床推广的价值。
Objective To observe the clinical efficacy of Xiangsha Liujunzi Decoction in the treatment of primary dysmenorrhea with cold blood stasis type. Methods 100 patients with primary dysmenorrhea with cold coagulation and blood stasis were randomly divided into treatment group and control group. The treatment group was treated with Xiangsha Liujunzi Decoction and the control group was given ibuprofen capsule. Results The VAS scores of the two groups were better than those before treatment( P < 0. 05). The difference of VAS scores between the two groups was statistically significant( P < 0. 01). The total effective rate was 86. 00% in the treatment group and 74. 00% in the control group. The total effective rate after treatment was statistically significant( P < 0. 01). After the follow-up for 3 months,the recurrence rate was 14. 28% in the treatment group and 85. 71% in the control group. The treatment group in the recurrence rate was significantly lower than the control group( P < 0. 01). Conclusion Xiangsha Liujunzi Decoction has significant clinical effect in treating primary dysmenorrheal with cold coagulation and blood stasis. The recurrence rate is low and it has clinical promotion value.
Objective To observe the clinical efficacy of Xiangsha Liujunzi Decoction in the treatment of primary dysmenorrhea with cold blood stasis type. Methods 100 patients with primary dysmenorrhea with cold coagulation and blood stasis were randomly divided into treatment group and control group. The treatment group was treated with Xiangsha Liujunzi Decoction and the control group was given ibuprofen capsule. Results The VAS scores of the two groups were better than those before treatment( P < 0. 05). The difference of VAS scores between the two groups was statistically significant( P < 0. 01). The total effective rate was 86. 00% in the treatment group and 74. 00% in the control group. The total effective rate after treatment was statistically significant( P < 0. 01). After the follow-up for 3 months,the recurrence rate was 14. 28% in the treatment group and 85. 71% in the control group. The treatment group in the recurrence rate was significantly lower than the control group( P < 0. 01). Conclusion Xiangsha Liujunzi Decoction has significant clinical effect in treating primary dysmenorrheal with cold coagulation and blood stasis. The recurrence rate is low and it has clinical promotion value.
引文
[1]尤昭玲.中西医结合妇产科[M].北京:中国中医药出版社,2006:453.
[2]罗晶.痛经方周期性治疗寒凝型原发性痛经临床观察[J].上海中医药杂志,2011,45(1):57-59.
[3]乐杰.妇产科学[M]. 7版,北京:人民卫生出版社,2011:318-910.
[4]中华中医药学会.中医妇科常见病诊疗指南[M].北京:中国中医药出版社,2012:26-28.
[5]谭冠先.疼痛诊疗学[M]. 3版.北京:人民卫生出版社,2011:12.
[6]国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:234.
[7]李泽焰,张洪梅,李泽平.加减当归四逆汤在子宫内膜异位症疼痛中的效果分析[J].中国继续医学教育,2015,7(15):173-174.
[8]喻姿容,阳书华,刘平红,等.调经止痛汤治疗原发性痛经89例临床观察[J].光明中医,2019,34(1):75.
[9]张景岳.景岳全书·妇人规[M].北京:中国医药科技出版社,2017:11.
[10]李红.用少腹逐瘀汤治疗寒凝血瘀型原发性痛经的疗效观察[J].求医问药,2013,11(16):44-45.
[11]龚小健,吴知行,陈真,等.川续断DA303对大鼠子宫的作用[J].中国药科大学学报,1996,27(1):48-51.
[12]李宝军,刘志强.当归四逆汤在妇科临床中的应用研究[J].当代医学,2015,21(5):11-12.
[2]罗晶.痛经方周期性治疗寒凝型原发性痛经临床观察[J].上海中医药杂志,2011,45(1):57-59.
[3]乐杰.妇产科学[M]. 7版,北京:人民卫生出版社,2011:318-910.
[4]中华中医药学会.中医妇科常见病诊疗指南[M].北京:中国中医药出版社,2012:26-28.
[5]谭冠先.疼痛诊疗学[M]. 3版.北京:人民卫生出版社,2011:12.
[6]国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2012:234.
[7]李泽焰,张洪梅,李泽平.加减当归四逆汤在子宫内膜异位症疼痛中的效果分析[J].中国继续医学教育,2015,7(15):173-174.
[8]喻姿容,阳书华,刘平红,等.调经止痛汤治疗原发性痛经89例临床观察[J].光明中医,2019,34(1):75.
[9]张景岳.景岳全书·妇人规[M].北京:中国医药科技出版社,2017:11.
[10]李红.用少腹逐瘀汤治疗寒凝血瘀型原发性痛经的疗效观察[J].求医问药,2013,11(16):44-45.
[11]龚小健,吴知行,陈真,等.川续断DA303对大鼠子宫的作用[J].中国药科大学学报,1996,27(1):48-51.
[12]李宝军,刘志强.当归四逆汤在妇科临床中的应用研究[J].当代医学,2015,21(5):11-12.